NGL Fine-Chem Limited develops and manufactures veterinary APIs, human APIs, intermediates, and finished dosage forms in India, Europe, the Asia Pacific, the United States, and internationally.
NGL Fine-Chem Limited (NGLFINE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The NGLFINE share price is ₹2,878.10 (+0.63% today), with a market capitalisation of ₹18B and a price-to-earnings (P/E) ratio of 31.1. MarketRipple tracks the NGLFINE investment thesis, the ripple-chain impact of market events on NGL Fine-Chem Limited, and the Healthcare sector outlook.
Open
₹2,950.00
High
₹2,990.60
Low
₹2,848.80
Prev. Close
₹2,860.20
52W High
₹3,602.00
52W Low
₹1,271.00
Day range
₹2,848.80–₹2,990.60
52-week range
₹1,271.00–₹3,602.00
Volume
2K
P/E
31.1
ROE
14.6%
D/E
0.37
Margin
10.7%
NGL Fine-Chem Limited (NSE: NGLFINE) is currently trading at ₹2,878.10 (+0.63%).
NGL Fine-Chem Limited's market capitalization is ₹18B.
NGL Fine-Chem Limited's price-to-earnings (P/E) ratio is 31.1.
NGL Fine-Chem Limited operates in the Healthcare sector (Drug Manufacturers - General).